Resources

Results showed that the intervention will be cost effective.

Basal insulin/GLP-1 combination medications versus each therapy separately for patients with type 2 diabetes: the combination medications are associated with all of the following properties EXCEPT: A. Greater A1c reduction B. Less insulin use C. Lower rates of hypoglycemia D. Weight gain Follow the link to see if you got the right answer!

Dr. W. Timothy Garvey MD, FACE, professor of Medicine and Chair of the Department of Nutrition Sciences at the University of Alabama at Birmingham, discusses diabetes and obesity in this exclusive interview at the AACE 26th Annual Scientific & Clinical Congress in Austin, Texas.

Which class of drugs would you prefer for a person with an A1c of 5.6%? 1) Only diet and exercise information 2) A GLP-1 receptor agonist 3) SGLT-2 Inhibitor 4) Metformin 5) Sulfonylurea Follow the link to share your opinion and see what your colleagues think!

Dr. W. Timothy Garvey talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about definition, treatment, and impact of obesity. Dr. W. Timothy Garvey MD, FACE  is a professor of Medicine and Chair of the Department of Nutrition Sciences at the University of …

Dr. W. Timothy Garvey talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about his message to medical professionals about the benefits of weight loss therapy in the treatment of type 2 diabetes. Dr. W. Timothy Garvey MD, FACE  is a professor of …

Dr. W. Timothy Garvey talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the differences in the various obesity guidelines. Dr. W. Timothy Garvey MD, FACE  is a professor of Medicine and Chair of the Department of Nutrition Sciences at the University …

In a talk with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas, Dr. W. Timothy Garvey explains a new medical diagnostic term for obesity. Dr. W. Timothy Garvey MD, FACE  is a professor of Medicine and Chair of the Department of Nutrition Sciences at the …

Dr. W. Timothy Garvey shares his thoughts about the impact of obesity on other medical conditions and complications with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas. Dr. W. Timothy Garvey MD, FACE  is a professor of Medicine and Chair of the Department of …

In part 1 of this Exclusive Interview, Dr. Vigerust discusses his role at molecular diagnostics company MyGenetx, and how diagnostic testing can reveal underlying genetic predispositions that can put diabetes patients at greater risk of cardiovascular events.